Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
7.02
+0.20 (2.93%)
Apr 8, 2026, 10:22 AM EDT - Market open
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $408.62 million as of April 8, 2026. Its market cap has increased by 3.38% in one year.
Market Cap
408.62M
Enterprise Value
414.24M
1-Year Change
3.38%
Ranking
Category
Stock Price
$7.02
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $408.62M, a decrease of -81.27%. That is a compound annual growth rate of -28.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 396.97M | -15.95% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | 2.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 421.46M |
| Vanda Pharmaceuticals | 411.98M |
| XOMA Royalty | 402.16M |
| Sutro Biopharma | 396.79M |
| Century Therapeutics | 393.59M |
| Armata Pharmaceuticals | 386.48M |
| Neumora Therapeutics | 385.93M |
| Enanta Pharmaceuticals | 384.51M |